AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that financial
results for the company's fourth quarter and year ended December 31,
2011 will be released before the market opens ... read more
AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that members
of the company’s management team are scheduled to present a corporate
overview at several upcoming investment conferences. The conference ... read more
AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that the AVEO
management team will host a conference call on Tuesday, January 3, 2012
at 8:30 a.m. (ET). The call ... read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) and Boehringer Ingelheim today
announced that they have entered into an agreement for large-scale
process development and clinical manufacturing of ficlatuzumab, AVEO’s
... read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today reported consolidated
financial results for the third quarter of 2011 and provided an update
on the tivozanib clinical program.
... read more
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced that the
company’s management will present a company overview at upcoming
investment conferences.
... read more